News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange
Mydecine Innovations Group
Psilocybin For Depression Will Be Studied in a Clinical Trial at Karolinska Institutet - First Time in Sweden
No items found.
Dr. Peter Facchini, MagicMed Industries
Enveric Biosciences
Dr. Peter Facchini | MagicMed Industries
Enveric Biosciences
Mydecine Innovations Group Subsidiary NeuroPharm Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities
Mydecine Innovations Group
Mind Cure Announces Addition of Neuroscientist Dr. Wolfram Tetzlaff to Scientific Advisory Board
MINDCURE
Nova Mentis Life Science Signs Agreement to Acquire 100% of Psychedelic-Focused Autism Research Company Pilz BioScience Corp.
Nova Mentis Life Science
MindMed Announces $25 Million Bought Deal Public Offering
Mind Medicine (MindMed)
Core One Labs Signs Letter of Intent to Acquire Vocan Viotechnologies
Core One Labs Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.